Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 65

1.

Validity of reported Medicare Part D enrollment in the Medical Expenditure Panel Survey.

Hill SC, Zuvekas SH, Zodet MW.

Med Care Res Rev. 2012 Dec;69(6):737-50. doi: 10.1177/1077558712457595. Epub 2012 Aug 28.

PMID:
22930311
2.

Validating household reports of health care use in the medical expenditure panel survey.

Zuvekas SH, Olin GL.

Health Serv Res. 2009 Oct;44(5 Pt 1):1679-700. doi: 10.1111/j.1475-6773.2009.00995.x. Epub 2009 Jul 13.

3.

Implications of the accuracy of MEPS prescription drug data for health services research.

Hill SC, Zuvekas SH, Zodet MW.

Inquiry. 2011 Fall;48(3):242-59.

PMID:
22235548
4.

PDP or MA-PD? Medicare part D enrollment decisions in CMS Region 25.

Cline RR, Worley MM, Schondelmeyer SW, Schommer JC, Larson TA, Uden DL, Hadsall RS.

Res Social Adm Pharm. 2010 Jun;6(2):130-42. doi: 10.1016/j.sapharm.2010.04.002.

PMID:
20511112
5.

Improvements in Medicare Part D risk adjustment: beneficiary access and payment accuracy.

Kautter J, Ingber M, Pope GC, Freeman S.

Med Care. 2012 Dec;50(12):1102-8. doi: 10.1097/MLR.0b013e318269eb20.

PMID:
22922436
6.

Prescription coverage, use and spending before and after Part D implementation: a national longitudinal panel study.

Safran DG, Strollo MK, Guterman S, Li A, Rogers WH, Neuman P.

J Gen Intern Med. 2010 Jan;25(1):10-7. doi: 10.1007/s11606-009-1134-2. Epub 2009 Oct 31.

7.
8.

Medicare Part D is associated with reducing the financial burden of health care services in Medicare beneficiaries with diagnosed diabetes.

Li R, Gregg EW, Barker LE, Zhang P, Zhang F, Zhuo X, Williams DE, Soumerai SB.

Med Care. 2013 Oct;51(10):888-93. doi: 10.1097/MLR.0b013e3182a53d95.

PMID:
23969594
9.

Part D plan enrollment by uninsured medicare beneficiaries.

Maciejewski ML, Farley JF, Hansen RA, Wei D, Harman JS.

Med Care. 2010 Feb;48(2):183-6. doi: 10.1097/MLR.0b013e3181bd4e0a.

PMID:
20057332
10.

Drug benefit changes under Medicare Advantage Part D: heterogeneous effects on pharmaceutical use and expenditures.

Ettner SL, Steers WN, Turk N, Quiter ES, Mangione CM.

J Gen Intern Med. 2011 Oct;26(10):1195-200. doi: 10.1007/s11606-011-1766-x. Epub 2011 Jun 28.

11.

The impact of Medicare Part D on out-of-pocket costs for prescription drugs, medication utilization, health resource utilization, and preference-based health utility.

Liu FX, Alexander GC, Crawford SY, Pickard AS, Hedeker D, Walton SM.

Health Serv Res. 2011 Aug;46(4):1104-23. doi: 10.1111/j.1475-6773.2011.01273.x. Epub 2011 May 24.

12.

Accuracy of Medicare expenditures in the medical expenditure panel survey.

Zuvekas SH, Olin GL.

Inquiry. 2009 Spring;46(1):92-108.

PMID:
19489486
13.

Impact of cost sharing on prescription drugs used by Medicare beneficiaries.

Goedken AM, Urmie JM, Farris KB, Doucette WR.

Res Social Adm Pharm. 2010 Jun;6(2):100-9. doi: 10.1016/j.sapharm.2010.03.003. Epub 2010 May 7.

PMID:
20511109
14.

The effect of Medicare Part D on health care utilization for non-elderly Medicare recipients with disabilities.

Nelson RE, Nelson SL, Huttner B, Gundlapalli A.

Disabil Health J. 2014 Jan;7(1):64-9. doi: 10.1016/j.dhjo.2013.07.003. Epub 2013 Sep 19.

PMID:
24411509
15.

Cost-related medication nonadherence among beneficiaries with depression following Medicare Part D.

Zivin K, Madden JM, Graves AJ, Zhang F, Soumerai SB.

Am J Geriatr Psychiatry. 2009 Dec;17(12):1068-76. doi: 10.1097/JGP.0b013e3181b972d1.

16.

Benzodiazepine use and expenditures for Medicare beneficiaries and the implications of Medicare Part D exclusions.

Yang HW, Simoni-Wastila L, Zuckerman IH, Stuart B.

Psychiatr Serv. 2008 Apr;59(4):384-91. doi: 10.1176/ps.2008.59.4.384.

17.

Should healthy Medicare beneficiaries postpone enrollment in Medicare Part D?

Atherly A, Dowd B.

Health Econ. 2009 Aug;18(8):921-31. doi: 10.1002/hec.1413.

PMID:
18972327
18.
19.

Prescription drug coverage and effects on drug expenditures among elderly Medicare beneficiaries.

Huh S, Rice T, Ettner SL.

Health Serv Res. 2008 Jun;43(3):810-32. doi: 10.1111/j.1475-6773.2007.00804.x.

20.

Confronting "confounding by health system use" in Medicare Part D: comparative effectiveness of propensity score approaches to confounding adjustment.

Polinski JM, Schneeweiss S, Glynn RJ, Lii J, Rassen JA.

Pharmacoepidemiol Drug Saf. 2012 May;21 Suppl 2:90-8. doi: 10.1002/pds.3250.

Supplemental Content

Support Center